Rare diseases Marathon sells Duchenne drug to PTC PTC says it will make changes to the price after abandoned launch last month.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News J&J: drug price rises below 10% since 2012 Janssen unit responds to criticism from president Trump over pricing.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Pharma must slash rare disease drug prices - patient organis... More rare disease drugs must also be approved, says EURORDIS.
News Doctors dismayed by report of NHS AI proposal The British Medical Association has branded a leaked proposal to rein back NHS recruitment and use more AI to compensate a "massive gamble."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
